Volume 20, Number 1—January 2014
Dispatch
Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe
Table
Characteristics of participants in study of MDR TB, Harare, Zimbabwe, 2011–2012*
Characteristic |
MDR-TB, n = 25 |
Monoresistant TB, n = 14 |
Drug-sensitive TB, n = 90 |
Unconfirmed TB, n = 84 |
p value |
---|---|---|---|---|---|
Age, median (IQR) | 34 (27–42) | 35 (29–45) | 37 (30–44) | 39 (32–48) | 0.67 |
Male, no. (%) |
13 (52) |
6 (43) |
58 (64) |
48 (57) |
0.36 |
Retreatment category, no. (%) | |||||
Treatment failure | 9 (36) | 0 | 9 (10) | 21 (25) | <0.001 |
Late smear conversion | 8 (32) | 1 (7) | 30 (33) | 13 (16) | |
Default | 0 (0.0) | 2 (14) | 13 (14) | 7 (8) | |
Relapse | 7 (28) | 7 (50) | 34 (38) | 34 (41) | |
New |
1 (4) |
4 (29) |
1 (1) |
4 (5) |
|
Sputum smear positivity, no. (%) |
20 (80) |
7 (50) |
52 (53) |
6 (7) |
<0.001 |
HIV infection, no. (%) | 18 (72) | 13 (93) | 57 (65) | 69 (82) | 0.02 |
Antiretroviral treatment, no. (%) |
14 (78) |
10 (77) |
41 (72) |
52 (75) |
0.95 |
Time receiving TB treatment, median (IQR) |
98 (4–175) |
0 (0–3) |
31 (2–103) |
101 (5–186) |
0.03 |
Prior treatment courses, no. (%) | |||||
None | 8 (32) | 5 (36) | 30 (33) | 21 (25) | 0.52 |
1 | 12 (48) | 7 (50) | 40 (44) | 40 (48) | |
≥2 | 5 (20) | 2 (14) | 20 (22) | 22 (27) |
*Retreatment classification was defined according to international standards (8); late smear conversion was defined as sputum AFB smear-positivity after month 3 but before month 5 of treatment. Monoresistant TB was defined as resistance to either isoniazid or rifampin, but not both. The denominator for antiretroviral treatment included persons with HIV infection. MDR TB, multidrug-resistant tuberculosis; IQR, interquartile range; AFB, acid-fast bacilli.
References
- World Health Organization. Multidrug and extensively drug-resistant tuberculosis: 2010 global report on surveillance and response. Geneva: The Organization; 2010 [cited 2013 Aug 22]. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
- World Health Organization. Global tuberculosis report 2012 [cited 2013 Jul 28]. http://www.who.int/tb/publications/global_report/en
- Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, Churchyard GJ, Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet. 2010;376:1244–53. DOIPubMedGoogle Scholar
- Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010. Bull World Health Organ. 2012;90:111–9D.
- Marais BJ, Mlambo CK, Rastogi N, Zozio T, Duse AG, Victor TC, Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa. J Clin Microbiol. 2013;51:1818–25.
- InRegional Office for Southern Africa. IOM detects possible TB problem amongst returning migrants at Plumtree Centre, Zimbabwe. A Bulletin of News, Information, and Analysis on Migration Health in Southern Africa. Issue 2, Nov 2009.
- Makamure B, Mhaka J, Makumbirofa S, Mutetwa R, Mupfumi L, Mason P, Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in harare, zimbabwe. PLoS ONE. 2013;8:e55872 . DOIPubMedGoogle Scholar
- Mboma SM, Houben RM, Glynn JR, Sichali L, Drobniewski F, Mpunga J, Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural Malawi. PLoS ONE. 2013;8:e58192. DOIPubMedGoogle Scholar
- Samo Gudo P, Cuna Z, Coelho E, Maungate S, Borroni E, Miotto P, Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey. Eur Respir J. 2011;38:222–4. DOIPubMedGoogle Scholar
- Sanchez-Padilla E, Dlamini T, Ascorra A, Rusch-Gerdes S, Tefera ZD, Calain P, High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009–2010. Emerg Infect Dis. 2012;18:29–37. DOIPubMedGoogle Scholar
- World Health Organization. Zimbabwe tuberculosis profile, 2012 [cited 2012 Oct 13]. https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ZW&outtype=PDF
- Cohen T, Colijn C, Wright A, Zignol M, Pym A, Murray M. Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med. 2008;177:1302–6. DOIPubMedGoogle Scholar